Business Context and Reporting Period
This Form 8-K Current Report from Omega Healthcare Investors, Inc. (OHI) covers events occurring on January 1, 2025, with the report dated January 6, 2025. The filing details a significant leadership transition involving the appointment of new executive officers and the departure of the Chief Operating Officer.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data presented is limited to executive compensation terms and severance arrangements.
- New Executive Base Salaries: Matthew Gourmand (President) at $550,000 annually; Vikas Gupta (Chief Investment Officer) at $525,000 annually.
- Bonus Opportunity: 125% of annual base salary for both new executives at the high level of performance.
- Severance Terms: Potential payment of two times the sum of annual base salary and the three-year average annual bonus, plus 18 months of healthcare premiums for termination without cause or for good reason.
- Consulting Fee: $10,000 per month for the departing COO, Daniel J. Booth, through January 1, 2026.
Material Changes Versus Prior Period
The primary material change is the restructuring of the executive leadership team effective January 1, 2025:
- Appointments: Matthew Gourmand promoted from Senior Vice President of Corporate Strategy & Investor Relations to President. Vikas Gupta promoted from Senior Vice President of Acquisitions & Development to Chief Investment Officer.
- Departure: Daniel J. Booth, Chief Operating Officer, terminated his employment effective January 2, 2025, following a mutual agreement.
- Contract Extensions: Employment agreements for other named executive officers were amended to extend terms through December 31, 2027, with revised annual salaries.
Guidance, Outlook, and Risks
The filing contains no forward-looking financial guidance, revenue outlook, or market commentary. The primary focus is on the execution of employment contracts and transition logistics.
- Transition Risks: The company has entered into a Transition Agreement and a Consulting Agreement with the departing COO to ensure a smooth handover of responsibilities through January 1, 2026.
- Legal Contingencies: Separation benefits for Mr. Booth are conditioned on the execution of a general release of claims and compliance with post-termination covenants.
- Non-Compete Covenants: New executives are subject to two-year non-competition and non-solicitation covenants post-termination.
Investor Verification Checklist
- Verify the full text of the New Employment Agreements for Mr. Gourmand and Mr. Gupta, which will be filed as exhibits to the Q1 2025 Form 10-Q.
- Review the Transition Agreement and Consulting Agreement (Exhibits 10.1 and 10.2) to understand the specific obligations and costs associated with Mr. Booth's departure.
- Confirm the revised salary amounts for other named executive officers in the upcoming quarterly report.
- Monitor the press release (Exhibit 99.1) for any additional context on the strategic rationale behind the leadership changes.